These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6278910)

  • 1. Role of calcium-blocking agents in treatment of cardiac arrhythmias related to myocardial ischemia.
    Surawicz B
    Am Heart J; 1982 Apr; 103(4 Pt 2):698-706. PubMed ID: 6278910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol.
    Bergey JL; Wendt RL; Nocella K; McCallum JD
    Eur J Pharmacol; 1984 Jan; 97(1-2):95-103. PubMed ID: 6698112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ischemic intervention as prognosis improvement in patients with coronary artery disease, with special focus on verapamil.
    Jespersen CM
    Am J Cardiol; 1996 Jun; 77(16):32D-36D. PubMed ID: 8677896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of calcium antagonists for cardiac arrhythmias.
    Singh BN; Nademanee K
    Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow inward current and cardiac arrhythmias.
    Gilmour RF; Zipes DP
    Am J Cardiol; 1985 Jan; 55(3):89B-101B. PubMed ID: 2857519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers and early ischemic ventricular arrhythmias: electrophysiological versus anti-ischemic effects.
    Coetzee WA; Dennis SC; Opie LH; Muller CA
    J Mol Cell Cardiol; 1987 May; 19 Suppl 2():77-97. PubMed ID: 3305966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms involved in reperfusion arrhythmias.
    Verrier RL; Hagestad EL
    Eur Heart J; 1986 May; 7 Suppl A():13-22. PubMed ID: 3522236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
    Apostolakos MJ; Varon ME
    New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists and cardiac arrhythmias in acute ischemia of the myocardium. Experimental data and their clinical implications].
    Carbonin PU; Di Gennaro M
    Minerva Cardioangiol; 1984 Nov; 32(11):773-8. PubMed ID: 6099525
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.
    Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F
    Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of heart arrhythmias with calcium antagonists].
    Bender F
    Z Kardiol; 1984; 73 Suppl 2():101-5. PubMed ID: 6084911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9.
    Curtis MJ; Walker MJ
    Br J Pharmacol; 1988 Aug; 94(4):1275-86. PubMed ID: 3207985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of cardiac arrhythmias by calcium antagonism.
    Nademanee K; Singh BN
    Ann N Y Acad Sci; 1988; 522():536-52. PubMed ID: 3288060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionic mechanisms of ischemia-related ventricular arrhythmias.
    Ducceschi V; Di Micco G; Sarubbi B; Russo B; Santangelo L; Iacono A
    Clin Cardiol; 1996 Apr; 19(4):325-31. PubMed ID: 8706374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    Billman GE; Hamlin RL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of calcium antagonists in cardiovascular therapy.
    Dargie H; Rowland E; Krikler D
    Br Heart J; 1981 Jul; 46(1):8-16. PubMed ID: 7023517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.
    Antman EM; Stone PH; Muller JE; Braunwald E
    Ann Intern Med; 1980 Dec; 93(6):875-85. PubMed ID: 6255848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.